Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.

Kjetil Bjørnevik, Trond Riise, Marianna Cortese, Trygve Holmøy, Margitta T Kampman, Sandra Magalhaes, Kjell-Morten Myhr, Christina Wolfson, Maura Pugliatti

Journal: Multiple sclerosis (Houndmills, Basingstoke, England) 2016;22(1):104-11

PMID: 26014605

Abstract

BACKGROUND

Several recent studies have found a higher risk of multiple sclerosis (MS) among people with a low level of education. This has been suggested to reflect an effect of smoking and lower vitamin D status in the social class associated with lower levels of education.

OBJECTIVE

The objective of this paper is to investigate the association between level of education and MS risk adjusting for the known risk factors smoking, infectious mononucleosis, indicators of vitamin D levels and body size.

METHODS

Within the case-control study on Environmental Factors In MS (EnvIMS), 953 MS patients and 1717 healthy controls from Norway reported educational level and history of exposure to putative environmental risk factors.

RESULTS

Higher level of education were associated with decreased MS risk (p trend = 0.001) with an OR of 0.53 (95% CI 0.41-0.68) when comparing those with the highest and lowest level of education. This association was only moderately reduced after adjusting for known risk factors (OR 0.61, 95% CI 0.44-0.83). The estimates remained similar when cases with disease onset before age 28 were excluded.

CONCLUSION

These findings suggest that factors related to lower socioeconomic status other than established risk factors are associated with MS risk.

© The Author(s), 2015.

Address: Department of Global Public Health and Primary Care, University of Bergen, Norway/The Norwegian Multiple Sclerosis Competence Center, Department of Neurology, Haukeland University Hospital, Norway [email protected].; Department of Global Public Health and Primary Care, University of Bergen, Norway/The Norwegian Multiple Sclerosis Competence Center, Department of Neurology, Haukeland University Hospital, Norway.; The Norwegian Multiple Sclerosis Competence Center, Department of Neurology, Haukeland University Hospital, Norway/The KG Jebsen Centre for MS-Research, Department of Clinical Medicine, University of Bergen, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Norway/Department of Neurology, Akershus University Hospital, Norway.; Department of Clinical Neurology, University of Tromsø, Norway/Centre for Clinical Research and Education, University Hospital of North Norway, Norway.; Department of Epidemiology and Biostatistics and Occupational Health, McGill University, Canada.; Department of Epidemiology and Biostatistics and Occupational Health, McGill University, Canada/Research Institute of the McGill University Health Centre, Canada.; Department of Global Public Health and Primary Care, University of Bergen, Norway/Department of Clinical and Experimental Medicine, University of Sassari, Italy/Division of Medicine, McGill University, Canada.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.